5-Amino-1MQ.
A research-stage metabolic compound studied for fat metabolism, lean-mass preservation, and cellular energy.
50 mg oral capsule · 2 mg/mL injectable.Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
Adults exploring 5-Amino-1MQ after provider review.
This isn't for you if
Provider review is required. Treatment is prescribed only when clinically appropriate.
5-Amino-1MQ
5-Amino-1MQ is a cutting-edge metabolic compound that acts as a powerful NNMT inhibitor.
By blocking this enzyme, it helps your body preserve higher levels of NAD+, boost cellular energy production, and shift into a more efficient fat-burning state. It promotes fat loss while helping preserve lean muscle, improves overall metabolism, and supports better energy levels.
Mechanism and fit.
By blocking NNMT, 5-Amino-1MQ may preserve higher levels of NAD⁺ — a coenzyme critical for cellular energy production. Preclinical research has explored its effects on fat-mass reduction, lean-muscle preservation, metabolic flexibility, and energy levels. It is often used as part of a broader physician-guided body-composition or metabolic protocol.
Who this is typically for.
- Adults pursuing physician-guided body-composition or metabolic optimization
- Patients who have completed baseline metabolic labs
- Patients seeking adjunctive support alongside structured nutrition and training
What patients
most often ask.
How is 5-Amino-1MQ different from NAD⁺ injections?
NAD⁺ injections supply the coenzyme directly. 5-Amino-1MQ works upstream by reducing the enzyme that depletes NAD⁺ precursors. They target the same end result through different mechanisms and are sometimes used together in physician-supervised programs.
Is it FDA-approved?
No. 5-Amino-1MQ is investigational, prescribed through licensed 503A compounding pharmacies under physician oversight.
Why are both oral and injectable forms available?
Oral 50 mg capsules suit daily protocols and are typically preferred for compliance. The 2 mg/mL injectable allows tighter dose control and is used in some specialist protocols where bioavailability is the priority.
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering 5-Amino-1MQ, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.